Envista Holdings Co. (NYSE:NVST) Shares Acquired by SG Americas Securities LLC

SG Americas Securities LLC increased its position in shares of Envista Holdings Co. (NYSE:NVST) by 594.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 108,509 shares of the company’s stock after purchasing an additional 92,880 shares during the quarter. SG Americas Securities LLC owned 0.06% of Envista worth $1,873,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in NVST. UMB Bank n.a. boosted its stake in Envista by 214.4% in the first quarter. UMB Bank n.a. now owns 2,094 shares of the company’s stock valued at $36,000 after acquiring an additional 1,428 shares during the period. Venturi Wealth Management LLC boosted its position in Envista by 528.4% during the 4th quarter. Venturi Wealth Management LLC now owns 1,948 shares of the company’s stock valued at $38,000 after purchasing an additional 1,638 shares during the period. Mitsubishi UFJ Trust & Banking Corp bought a new position in Envista during the 4th quarter worth $86,000. Tower Research Capital LLC TRC increased its position in Envista by 51.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 11,057 shares of the company’s stock worth $213,000 after buying an additional 3,751 shares during the period. Finally, Sterling Capital Management LLC lifted its stake in Envista by 53.9% in the fourth quarter. Sterling Capital Management LLC now owns 11,105 shares of the company’s stock valued at $214,000 after buying an additional 3,888 shares during the last quarter.

Analysts Set New Price Targets

Several research firms have recently commented on NVST. Piper Sandler lowered their price target on shares of Envista from $18.00 to $17.00 and set a “neutral” rating for the company in a research report on Wednesday, April 30th. JPMorgan Chase & Co. decreased their target price on shares of Envista from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Thursday, March 6th. Morgan Stanley set a $16.00 price target on Envista in a report on Tuesday, April 15th. Baird R W upgraded Envista from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 27th. Finally, Robert W. Baird raised Envista from a “neutral” rating to an “outperform” rating and increased their price objective for the stock from $21.00 to $23.00 in a report on Tuesday, May 27th. One analyst has rated the stock with a sell rating, nine have given a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $20.23.

Envista Price Performance

Shares of NYSE:NVST opened at $18.44 on Monday. The company has a market capitalization of $3.13 billion, a PE ratio of -2.84, a price-to-earnings-growth ratio of 1.27 and a beta of 0.99. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.76 and a current ratio of 2.04. The stock has a fifty day moving average of $17.09 and a 200-day moving average of $18.55. Envista Holdings Co. has a one year low of $14.22 and a one year high of $23.00.

Envista (NYSE:NVST) last announced its earnings results on Thursday, May 1st. The company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.20 by $0.04. The business had revenue of $616.90 million during the quarter, compared to the consensus estimate of $608.17 million. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. Envista’s revenue was down 1.1% compared to the same quarter last year. During the same period in the prior year, the business posted $0.26 earnings per share. As a group, equities analysts anticipate that Envista Holdings Co. will post 1 EPS for the current fiscal year.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.